Raptor Pharmaceutical Corp. (NASDAQ:RPTP) CEO Christopher M. Starr unloaded 32,896 shares of Raptor Pharmaceutical Corp. stock on the open market in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $10.60, for a total transaction of $348,697.60. Following the sale, the chief executive officer now directly owns 699,370 shares in the company, valued at approximately $7,413,322. Raptor Pharmaceuticals Corp. … Continue reading Why Need to Watch : Raptor Pharmaceuticals Corp. (NASDAQ:RPTP), Seaspan Corporation (NYSE:SSW), New York & Company Inc. (NYSE:NWY), DAL, BA